Dr. Howard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1601 Center Street
Suite 2K
Mobile, AL 36604Phone+1 251-434-3982- Is this information wrong?
Summary
- Dr. J. Harrison Howard is a Surgical Oncologist, specializing in Melanoma and Gastrointestinal Cancers. He has been involved in cutting edge immunotherapy trials for Melanoma and has been involved with the National Comprehensive Cancer Network (NCCN) practice guideline development.
Education & Training
- Saint John’s Cancer Institute/Providence Saint John’s Health CenterFellowship, Complex General Surgical Oncology, 2010 - 2012
- University of Alabama Medical CenterResidency, Surgery, 2003 - 2010
- University of Alabama School of MedicineClass of 2003
Certifications & Licensure
- AL State Medical License 2005 - 2024
- OH State Medical License 2012 - 2018
- CA State Medical License 2010 - 2012
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Rescue Rates for Talimogene laherparepvec Use in Loco-Regionally Progressing Cutaneous Melanoma Refractory to PD1 Inhibition.Morgan E Roberts, Frances G Sullivan, Thuy Phung, Katie Vines, Joe S Liles, John H Howard> ;The American Surgeon. 2024 Apr 2
- The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.Ashish Manne, Madhuri Mulekar, Daisy Escobar, Pranitha Prodduturvar, Yazan Fahmawi, Phillip Henderson, Osama Abdul-Rahim, Zeiad Hussain, Spencer Liles, Annabelle Fonse...> ;Journal of Cancer Research and Therapeutics. 2023 Oct 3
- 5 citationsOncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicent...James W Jakub, Michael Lowe, J Harrison Howard, Jeffrey M Farma, Amod Sarnaik, Todd Tuttle, Heather B Neuman, Charlotte E Ariyan, Abhineet Uppal, Steve Trocha, Georgia...> ;Annals of Surgical Oncology. 2022 Sep 1
- Join now to see all
Journal Articles
- Practices and Perceptions Among Surgical Oncologists in the Perioperative Care of Obese Cancer PatientsTasha M Hughes, Mary Dillhoff, Valerie Grignol, Jordan Cloyd, J Harrison Howard, Alicia Terando, Quinn Capers, Ingrid Woelfel, Sabrena Noria, Doreen Agnese, Lawrence A..., Annals of Surgical Oncology
- Does the Number of Sentinel Lymph Nodes Removed Affect the False Negative Rate for Head and Neck Melanoma?Srirama Josyula, Alicia M Terando, Walter T Lee, Paul J Mosca, Charles J Puza, John H Howard, Doreen M Agnese, Georgia M Beasley, Journal of Surgical Oncology
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: